Novo Nordisk Trial Flop Ripples Through Denmark’s Stock Market

Disappointing data from Novo Nordisk A/S is sending shockwaves across equities in Denmark, dragging the wider market down and underscoring how tightly the country’s fortunes are tied to the obesity-drug maker....

Redirecting to full article...